Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CPS TECHNOLOGIES CORP/DE/CPSH · Entity 7015 | SVP, Sales & Marketing | February 15, 2019 | February 19, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CPS TECHNOLOGIES CORP/DE/
Report date February 15, 2019 · Filed February 19, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $1.40 · Expires 2029-02-15 | Direct | 163,000 |
Reported balance
After 2019-02-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-02-15 · Grant · Acquired 3,000 · Balance 163,000 |
| Common Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $1.40 · Expires 2029-02-15 | Direct | 166,000 |
Reported balance
After 2019-02-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-02-15 · Grant · Acquired 3,000 · Balance 166,000 |
| Common Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $1.40 · Expires 2029-02-15 | Direct | 169,000 |
Reported balance
After 2019-02-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-02-15 · Grant · Acquired 3,000 · Balance 169,000 |
| Common Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $1.40 · Expires 2029-02-15 | Direct | 172,000 |
Reported balance
After 2019-02-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-02-15 · Grant · Acquired 3,000 · Balance 172,000 |
| Common Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $1.40 · Expires 2029-02-15 | Direct | 175,000 |
Reported balance
After 2019-02-15 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-02-15 · Grant · Acquired 3,000 · Balance 175,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2019 Filed Feb 19, 2019 22:16 UTC | CPS TECHNOLOGIES CORP/DE/ CPSH · Entity 7015 | GrantCommon Stock Options · Derivative | 3,000 | $1.40 Strike: $1.40 | $4,200.00 |
DisclosureSEC source: 0000814676-19-000007 · primary_doc.xml · derivative · entry 5 Breen Thomas E · CIK 0001689740 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock Options · 3,000 shares Expires 2029-02-15 Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 22:16 UTC | CPS TECHNOLOGIES CORP/DE/ CPSH · Entity 7015 | GrantCommon Stock Options · Derivative | 3,000 | $1.40 Strike: $1.40 | $4,200.00 |
DisclosureSEC source: 0000814676-19-000007 · primary_doc.xml · derivative · entry 4 Breen Thomas E · CIK 0001689740 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,000 Underlying: Common Stock Options · 3,000 shares Expires 2029-02-15 Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 22:16 UTC | CPS TECHNOLOGIES CORP/DE/ CPSH · Entity 7015 | GrantCommon Stock Options · Derivative | 3,000 | $1.40 Strike: $1.40 | $4,200.00 |
DisclosureSEC source: 0000814676-19-000007 · primary_doc.xml · derivative · entry 3 Breen Thomas E · CIK 0001689740 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,000 Underlying: Common Stock Options · 3,000 shares Expires 2029-02-15 Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 22:16 UTC | CPS TECHNOLOGIES CORP/DE/ CPSH · Entity 7015 | GrantCommon Stock Options · Derivative | 3,000 | $1.40 Strike: $1.40 | $4,200.00 |
DisclosureSEC source: 0000814676-19-000007 · primary_doc.xml · derivative · entry 2 Breen Thomas E · CIK 0001689740 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,000 Underlying: Common Stock Options · 3,000 shares Expires 2029-02-15 Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 22:16 UTC | CPS TECHNOLOGIES CORP/DE/ CPSH · Entity 7015 | GrantCommon Stock Options · Derivative | 3,000 | $1.40 Strike: $1.40 | $4,200.00 |
DisclosureSEC source: 0000814676-19-000007 · primary_doc.xml · derivative · entry 1 Breen Thomas E · CIK 0001689740 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,000 Underlying: Common Stock Options · 3,000 shares Expires 2029-02-15 Read SEC document |
| February 23, 2018 Filed Feb 26, 2018 23:08 UTC | CPS TECHNOLOGIES CORP/DE/ CPSH · Entity 7015 | GrantStock Options · Derivative | 7,000 | $1.53 Strike: $1.53 | $10,710.00 |
DisclosureSEC source: 0000814676-18-000001 · primary_doc.xml · derivative · entry 5 Breen Thomas E · CIK 0001689740 · SVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Stock Options · 7,000 shares Expires 2028-02-22 Read SEC document |
| February 23, 2018 Filed Feb 26, 2018 23:08 UTC | CPS TECHNOLOGIES CORP/DE/ CPSH · Entity 7015 | GrantStock Options · Derivative | 7,000 | $1.53 Strike: $1.53 | $10,710.00 |
DisclosureSEC source: 0000814676-18-000001 · primary_doc.xml · derivative · entry 4 Breen Thomas E · CIK 0001689740 · SVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,000 Underlying: Stock Options · 7,000 shares Expires 2028-02-23 Read SEC document |
| February 23, 2018 Filed Feb 26, 2018 23:08 UTC | CPS TECHNOLOGIES CORP/DE/ CPSH · Entity 7015 | GrantStock Options · Derivative | 7,000 | $1.53 Strike: $1.53 | $10,710.00 |
DisclosureSEC source: 0000814676-18-000001 · primary_doc.xml · derivative · entry 3 Breen Thomas E · CIK 0001689740 · SVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,000 Underlying: Stock Options · 7,000 shares Expires 2028-02-23 Read SEC document |
| February 23, 2018 Filed Feb 26, 2018 23:08 UTC | CPS TECHNOLOGIES CORP/DE/ CPSH · Entity 7015 | GrantStock Options · Derivative | 7,000 | $1.53 Strike: $1.53 | $10,710.00 |
DisclosureSEC source: 0000814676-18-000001 · primary_doc.xml · derivative · entry 2 Breen Thomas E · CIK 0001689740 · SVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,000 Underlying: Stock Options · 7,000 shares Expires 2028-02-23 Read SEC document |
| February 23, 2018 Filed Feb 26, 2018 23:08 UTC | CPS TECHNOLOGIES CORP/DE/ CPSH · Entity 7015 | GrantStock Options · Derivative | 7,000 | $1.53 Strike: $1.53 | $10,710.00 |
DisclosureSEC source: 0000814676-18-000001 · primary_doc.xml · derivative · entry 1 Breen Thomas E · CIK 0001689740 · SVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,000 Underlying: Stock Options · 7,000 shares Expires 2028-02-23 Read SEC document |
| February 17, 2017 Filed Feb 27, 2017 13:37 UTC | CPS TECHNOLOGIES CORP/DE/ CPSH · Entity 7015 | GrantCommon Stock · Derivative | 5,000 | $1.57 Strike: $1.57 | $7,850.00 |
DisclosureSEC source: 0000814676-17-000007 · primary_doc.xml · derivative · entry 5 Breen Thomas E · CIK 0001689740 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 5,000 shares Expires 2027-02-17 Read SEC document |
| February 17, 2017 Filed Feb 27, 2017 13:37 UTC | CPS TECHNOLOGIES CORP/DE/ CPSH · Entity 7015 | GrantCommon Stock · Derivative | 5,000 | $1.57 Strike: $1.57 | $7,850.00 |
DisclosureSEC source: 0000814676-17-000007 · primary_doc.xml · derivative · entry 4 Breen Thomas E · CIK 0001689740 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 5,000 shares Expires 2027-02-17 Read SEC document |
| February 17, 2017 Filed Feb 27, 2017 13:37 UTC | CPS TECHNOLOGIES CORP/DE/ CPSH · Entity 7015 | GrantCommon Stock · Derivative | 5,000 | $1.57 Strike: $1.57 | $7,850.00 |
DisclosureSEC source: 0000814676-17-000007 · primary_doc.xml · derivative · entry 3 Breen Thomas E · CIK 0001689740 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Stock · 5,000 shares Expires 2027-02-17 Read SEC document |
| February 17, 2017 Filed Feb 27, 2017 13:37 UTC | CPS TECHNOLOGIES CORP/DE/ CPSH · Entity 7015 | GrantCommon Stock · Derivative | 5,000 | $1.57 Strike: $1.57 | $7,850.00 |
DisclosureSEC source: 0000814676-17-000007 · primary_doc.xml · derivative · entry 2 Breen Thomas E · CIK 0001689740 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 5,000 shares Expires 2027-02-17 Read SEC document |
| February 17, 2017 Filed Feb 27, 2017 13:37 UTC | CPS TECHNOLOGIES CORP/DE/ CPSH · Entity 7015 | GrantCommon Stock · Derivative | 5,000 | $1.57 Strike: $1.57 | $7,850.00 |
DisclosureSEC source: 0000814676-17-000007 · primary_doc.xml · derivative · entry 1 Breen Thomas E · CIK 0001689740 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 5,000 shares Expires 2027-02-17 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.